Correlation Between PT Astra and Endonovo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PT Astra and Endonovo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Astra and Endonovo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Astra International and Endonovo Therapeutics, you can compare the effects of market volatilities on PT Astra and Endonovo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Astra with a short position of Endonovo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Astra and Endonovo Therapeutics.

Diversification Opportunities for PT Astra and Endonovo Therapeutics

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between PTAIF and Endonovo is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding PT Astra International and Endonovo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endonovo Therapeutics and PT Astra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Astra International are associated (or correlated) with Endonovo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endonovo Therapeutics has no effect on the direction of PT Astra i.e., PT Astra and Endonovo Therapeutics go up and down completely randomly.

Pair Corralation between PT Astra and Endonovo Therapeutics

Assuming the 90 days horizon PT Astra International is expected to generate 0.2 times more return on investment than Endonovo Therapeutics. However, PT Astra International is 5.11 times less risky than Endonovo Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Endonovo Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  29.00  in PT Astra International on September 3, 2024 and sell it today you would earn a total of  8.00  from holding PT Astra International or generate 27.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PT Astra International  vs.  Endonovo Therapeutics

 Performance 
       Timeline  
PT Astra International 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in PT Astra International are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating forward indicators, PT Astra reported solid returns over the last few months and may actually be approaching a breakup point.
Endonovo Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Endonovo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

PT Astra and Endonovo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PT Astra and Endonovo Therapeutics

The main advantage of trading using opposite PT Astra and Endonovo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Astra position performs unexpectedly, Endonovo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endonovo Therapeutics will offset losses from the drop in Endonovo Therapeutics' long position.
The idea behind PT Astra International and Endonovo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios